Core Insights - Walgreens Boots Alliance (WBA) reported quarterly earnings of $0.38 per share, exceeding the Zacks Consensus Estimate of $0.34 per share, but down from $0.63 per share a year ago, indicating an earnings surprise of +11.76% [1] - The company achieved revenues of $38.99 billion for the quarter ended May 2025, surpassing the Zacks Consensus Estimate by 6.49% and up from $36.35 billion year-over-year [2] - Walgreens shares have increased by approximately 21.2% since the beginning of the year, significantly outperforming the S&P 500's gain of 3.6% [3] Earnings Outlook - The future performance of Walgreens stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is $0.25 on revenues of $36.98 billion, and for the current fiscal year, it is $1.69 on revenues of $151.46 billion [7] Industry Context - The Retail - Pharmacies and Drug Stores industry, to which Walgreens belongs, is currently ranked in the top 2% of over 250 Zacks industries, indicating a favorable outlook for the sector [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked using tools like the Zacks Rank [5][6]
Walgreens Boots Alliance (WBA) Q3 Earnings and Revenues Beat Estimates